V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011707 | 280011403 | 1.7 | 70 | Palliative (P) | 2017-03-18 | 2017-03-21 | VAC | N | N | 280029044 | CAV |
| 280011708 | 280006083 | 1.77 | 67 | Palliative (P) | 2015-07-07 | 2015-07-07 | DE-ESCALATE TRIAL | 2 | N | 280029057 | DE-ESCALATE TRIAL |
| 280011709 | 280006088 | 1.73 | 81 | Palliative (P) | 2015-01-13 | 2015-02-14 | Irinotecan + Temozolomide | null | null | 280029070 | IRINOTECAN + TEMOZOLOMIDE |
| 280011710 | 280006093 | 1.75 | 46.6 | Palliative (P) | 2016-03-06 | 2016-10-18 | EW Rel rEECur Irinotecan/Temozolomide | 02 | N | 280029090 | VAI |
| 280011711 | 280011937 | 1.7 | 56.6 | Palliative (P) | 2018-02-08 | 2018-02-14 | CYCLOPHOSPHAMIDE | 2 | N | 280029101 | CYCLOPHOSPHAMIDE |
| 280011712 | 280006102 | 1.76 | 63.2 | Adjuvant (A) | 2017-05-28 | 2017-06-08 | VAC | 01 | N | 280029119 | CAV |
| 280011713 | 280010685 | 0 | 48.8 | Curative (C) | 2015-08-28 | 2016-01-11 | Oxaliplatin + Modified de Gramont | N | N | 280029120 | OXALIPLATIN + MDG |
| 280011714 | 280009205 | 1.68 | 102.7 | Palliative (P) | 2014-08-03 | 2014-08-10 | Cyclophosphamide oral | N | N | 280029152 | CYCLOPHOSPHAMIDE |
| 280011715 | 280006118 | 1.76 | 97 | Palliative (P) | 2017-05-31 | 2017-05-31 | Doxorubicin + Ifosfamide | null | null | 280029169 | DOXORUBICIN + IFOSFAMIDE |
| 280011716 | 280006129 | 1.6 | 89 | Curative (C) | 2018-04-17 | 2018-10-29 | Irinotecan + Modified De Gramont | N | N | 280029210 | IRINOTECAN + TEMOZOLOMIDE |
| 280011717 | 280006132 | 1.7 | 73.8 | null | 2012-03-04 | 2014-03-17 | Eribulin | N | N | 280029223 | CARBO + FLUOROURACIL |
| 280011718 | 280006134 | 1.81 | null | Palliative (P) | 2012-03-24 | 2016-11-20 | INTERFERON | 02 | N | 280029255 | CARBO + FLUOROURACIL |
| 280011719 | 280009220 | 1.6 | 109.4 | Palliative (P) | 2016-02-05 | 2016-12-30 | Cyclophosphamide PO +Vinorelbine IV | N | N | 280029309 | SUNITINIB |
| 280011720 | 280006158 | 1.89 | null | Palliative (P) | 2017-10-16 | 2017-10-28 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 280029362 | NIVOLUMAB |
| 280011721 | 280006165 | 1.81 | 9.2 | Neo-adjuvant (N) | 2016-11-16 | 2016-11-22 | Cisplatin + Fluorouracil + RT 5day | N | N | 280029388 | CETUXIMAB + IRINOTECAN |
| 280011722 | 280006173 | 1.6 | 68.9 | null | 2017-11-13 | 2017-12-18 | BCG Intravesical | N | N | 280029421 | CARBO + FLUOROURACIL |
| 280011723 | 280006186 | 1.62 | 64.8 | Palliative (P) | 2014-05-25 | 2014-05-31 | AFLIBERCEPT + FU + IRINOTECAN | null | null | 280029448 | CAPECITABINE + OXALIPLATIN |
| 280011724 | 280006195 | null | 58.8 | Palliative (P) | 2017-08-20 | 2018-06-07 | CARBOPLATIN + CETUXIMAB + FU | N | N | 280029471 | CARBOPLATIN + PEMETREXED |
| 280011725 | 280006212 | 1.69 | 97 | Curative (C) | 2017-09-27 | 2017-12-16 | Docetaxel 75mg/m2 (21 day) | N | N | 280029556 | BENDAMUSTINE + RITUXIMAB |
| 280011726 | 280006218 | 1.59 | 42.3 | Curative (C) | 2014-09-19 | 2014-09-20 | TRASTUZUMAB | N | N | 280029560 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280011727 | 280006237 | 0 | 70.2 | Curative (C) | null | 2018-02-21 | Capecitabine + Streptozocin | N | null | 280029642 | CARBOPLATIN + CETUXIMAB + FU |
| 280011728 | 280006239 | 1.75 | 100.2 | Palliative (P) | 2019-03-15 | 2019-06-06 | Etoposide oral | Y | N | 280029656 | ALEMTUZUMAB |
| 280011729 | 280006252 | 1.8 | 94.1 | Palliative (P) | 2018-01-13 | 2018-01-13 | IFOSFAMIDE + VINCRISTINE | N | N | 280029691 | CARBOPLATIN + CETUXIMAB + FU |
| 280011730 | 280006267 | 1.65 | 52 | Curative (C) | 2016-08-15 | 2016-08-20 | ECX | 01 | N | 280029727 | IVADO |
| 280011731 | 280006268 | 1.8 | 68 | Palliative (P) | 2017-11-02 | 2017-12-10 | Pazopanib | null | Y | 280029733 | CARBO + FLUOROURACIL |
| 280011732 | 280006274 | 1.7 | 97.4 | Palliative (P) | null | 2017-12-10 | CASPS TRIAL | 02 | N | 280029773 | PACMEL TRIAL |
| 280011733 | 280010729 | 1.72 | null | Neo-adjuvant (N) | 2018-09-05 | 2018-09-05 | VIDE | null | N | 280029779 | DACTINOMYCIN + VINCRISTINE |
| 280011734 | 280006279 | 1.86 | 60.6 | Curative (C) | 2017-08-20 | 2019-04-01 | IRINOTECAN + VINCRISTINE | N | N | 280029781 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 280011735 | 280009285 | 1.86 | 78.6 | Palliative (P) | 2017-02-26 | 2017-02-26 | Carboplatin + Cetux + FU (Cycle 1) | N | null | 280029782 | CAPECITABINE + CARBOPLATIN |
| 280011736 | 280006294 | 1.76 | 75.6 | Palliative (P) | null | 2018-08-29 | Vemurafenib | 02 | null | 280029813 | CARBO + FLUOROURACIL |
| 280011737 | 280006305 | 1.77 | 65 | Palliative (P) | 2018-08-15 | 2018-08-15 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 280029855 | NIVOLUMAB |
| 280011738 | 280006310 | null | 62.1 | Disease modification (D) | 2019-10-25 | 2019-10-27 | Capecitabine + Oxaliplatin 14day | N | N | 280029884 | BENDAMUSTINE + RITUXIMAB |
| 280011739 | 280006320 | 1.69 | 52.2 | Palliative (P) | 2019-10-09 | 2019-10-12 | Gemcitabine + Capecitabine | null | null | 280029953 | DOCETAXEL |
| 280011740 | 280006326 | 1.68 | null | Palliative (P) | 2017-02-09 | 2017-02-21 | Hydroxycarbamide | null | null | 280029968 | METHOTREXATE INTRATHECAL |
| 280011741 | 280006329 | 1.6 | 105.9 | Palliative (P) | null | 2018-12-31 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | N | N | 280029973 | CARBO + FLUOROURACIL |
| 280011742 | 280006330 | 1.67 | 76 | Neo-adjuvant (N) | null | 2014-09-30 | Pazopanib | null | null | 280029985 | NAB-PACLITAXEL |
| 280011743 | 280011774 | 1.83 | 64.8 | Palliative (P) | null | 2015-11-05 | Capecitabine | 02 | N | 280029991 | NIVOLUMAB |
| 280011744 | 280006336 | 1.65 | 59.1 | Curative (C) | 2014-06-25 | 2014-06-27 | Vinorelbine (oral) | null | null | 280030003 | ETOPOSIDE |
| 280011745 | 280006346 | 1.73 | null | Palliative (P) | 2018-09-27 | 2018-10-11 | Azacitidine | N | null | 280030037 | CARBOPLATIN + VINORELBINE |
| 280011746 | 280009323 | 1.63 | 79 | Palliative (P) | 2015-10-26 | 2015-11-26 | Cetuximab + CISPLATIN + FLUOROURACIL | N | null | 280030045 | GEDDIS TRIAL |
| 280011747 | 280006350 | 1.66 | 66.3 | Palliative (P) | 2019-02-04 | 2019-05-26 | VINORELBINE | 02 | N | 280030055 | GEMCARBO |
| 280011748 | 280006360 | 0 | null | Palliative (P) | 2018-01-19 | 2018-01-24 | VIDE | 2 | null | 280030067 | VINORELBINE |
| 280011749 | 280011777 | 1.81 | 59.7 | Palliative (P) | 2018-12-08 | 2018-12-08 | CAPECITABINE + CETUXIMAB + CISPLATIN | 02 | N | 280030070 | PEMETREXED |
| 280011750 | 280006366 | 1.61 | 92 | Not known (9) | 2017-11-18 | 2017-11-21 | Rituximab | 02 | N | 280030073 | VINCRISTINE |
| 280011752 | 280010753 | 1.75 | 18.18 | Palliative (P) | 2015-09-16 | 2016-07-13 | Capecitabine + Streptozocin | N | N | 280030118 | VIDE |
| 280011753 | 280009338 | 1.73 | null | Adjuvant (A) | 2018-06-29 | 2019-05-03 | NIVOLUMAB | N | N | 280030124 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280011754 | 280006391 | null | 65.5 | Palliative (P) | 2016-02-15 | 2016-03-06 | Docetaxel | null | null | 280030163 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 280011755 | 280010757 | 1.61 | 43.5 | Disease modification (D) | null | 2019-06-13 | OST Euramos 1 Closed Trial - M | N | N | 280030165 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280011756 | 280009345 | null | 83 | null | 2018-10-11 | 2018-10-14 | Rituximab | 2 | N | 280030167 | CARBOPLATIN + PEMETREXED |
| 280011757 | 280006408 | 1.77 | 11.1 | Disease modification (D) | 2015-11-15 | 2015-12-13 | CHOP R - 21 days | 02 | null | 280030189 | BCG |